The changes in intestinal flora increase intestinal permeability and promote LPS to enter the blood to activate the NF-κB signal pathway, which leads to chronic inflammation, endotoxemia, and increased fat accumulation, and ultimately leads to metabolic syndrome and obesity (73). The gene discussed is NFKB1; the disease is obesity disorder.